MNKD MANNKIND CORP

MNKD financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 899460 Exchange: Nasdaq SIC: 2834 (Pharmaceutical Preparations)
Showing 3 of 34 annual and 0 of 64 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Large accelerated filer
Entity Type
Operating
Public Float
$1.13B (Jun 2025)
Industry (SIC)
2834 Pharmaceutical Preparations
Incorporated
DE
Fiscal Year End
December (1231)
Phone
818-661-5000
EIN
133607736
Headquarters
DANBURY, CT, 06810
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$393.63M
Net Income
$-43.61M
Total Assets
$732.30M
Total Equity
$-67.20M
Total Debt
-
Free Cash Flow
$-18.14M
Ratios
Gross Margin
89.8%
Operating Margin
2.3%
Net Margin
-11.1%
Return on Equity
64.9%
Return on Assets
-6%
Current Ratio
1.72x
FCF / Assets
-2.5%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

MANNKIND CORP generated $348.97M of revenue in fiscal 2025, with net income of $5.86M and an operating cash inflow of $18.25M. At $348.97M, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. Compared with $285.50M in fiscal 2024, revenue recorded a 22.2% year-over-year increase. Diluted earnings per share were $0.02, translating the period’s attributable earnings into the amount reported for each diluted share. Against diluted EPS of $0.10 in fiscal 2024, the current result was 80.0% lower. Asset turnover was 0.44x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

Gross profit was $322.17M, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. Gross margin was 92.3%, so that share of each revenue unit remained after the cost of revenue reported for the period. Operating income was $38.80M, the earnings remaining from reported operations after the company’s recognized operating cost structure. The operating result equaled 11.1% of revenue, placing the absolute operating-income figure in the context of the company’s sales base. The bottom-line result was net income of $5.86M, after the operating, financing, tax, and other items recognized for the period. The final earnings result represented 1.7% of revenue, connecting the absolute net income figure with the company’s top-line scale. The earnings statement records $1.41M of pretax income, the profit base against which the reported tax provision can be assessed. Pretax income represented 0.4% of revenue, placing earnings before tax in the context of the company’s operating scale. An income-tax benefit of $4.46M improved the final result relative to pretax income or loss. The tax benefit equaled 316.7% of positive pretax income, lifting the after-tax result.

Liquidity and Capital Structure

Total assets were $792.18M, supported by $843.20M of liabilities and -$51.02M of shareholder equity. The company reported negative equity of -$51.02M, a capital deficit that reduces its ability to absorb losses through book equity. The near-term balance sheet paired $291.58M of current assets with $171.03M of current liabilities at the reporting date. Current assets covered current liabilities by 1.7x, leaving a positive buffer for near-term obligations. Cash and equivalents totaled $74.88M, identifying the most liquid reported component available within the broader current-asset balance. The cash balance equaled 43.8% of current liabilities, showing how much near-term coverage came from cash alone. Total debt was $354.64M, establishing the amount of borrowing carried within the company’s capital structure. Relative to total assets, debt measured 44.8%, showing how much of the asset base was matched by borrowing. Relative to total assets, liabilities measured 106.4%, complementing the separate equity-based view of the company’s capital structure. The cash-to-assets relationship was 9.5%, comparing reported cash and equivalents with the full positive asset balance.

Cash Flow and Earnings Quality

Operating activities produced a cash inflow of $18.25M, giving the cash-flow counterpart to the accrual-based profit measures reported for the year. The operating-cash-flow-to-net-income relationship was 3.11x, comparing cash generated by operations with the bottom-line earnings result. Capital spending was $4.57M, absorbing part of the cash generated from operations before free cash flow. Relative to operating cash flow, capital expenditures measured 25.0%, connecting investment intensity with the company’s cash-generation base. The combination of operating cash flow and capital spending produced $13.69M of positive free cash flow for the period. Relative to revenue, free cash flow equaled 3.9%, showing how much sales converted into cash after investment. The free-cash-flow-to-assets relationship was 1.7%, comparing post-investment cash with the balance-sheet asset base.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual (FY)
Quarterly 🔒
Chart 🔒
Annual financial statements for MANNKIND CORP
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $348.97M $285.50M $198.96M
Cost of Revenue $26.80M $17.43M $20.86M
Gross Profit $322.17M $268.08M $178.10M
OPERATING EXPENSES
R&D Expense $66.35M $45.89M $31.28M
SG&A Expense $144.14M $94.33M $94.31M
Other Operating Expenses (derived) $72.88M $55.27M $43.82M
Operating Income $38.80M $72.59M $8.68M
NON-OPERATING INCOME / EXPENSE
Interest Expense - - $15.15M
Interest Income $8.05M $12.62M $6.15M
Other Income/Expense $-1.01M $32.00K $122.00K
Pretax Income $1.41M $30.52M $-10.38M
Income Tax $-4.46M $2.93M $1.56M
Net Income $5.86M $27.59M $-11.94M
PER SHARE & SUPPLEMENTAL
Diluted EPS $0.02 $0.10 $-0.04
Diluted Shares 314.11M 283.84M 267.01M
EBITDA $51.09M $79.96M $13.21M
Depreciation & Amortization $12.28M $7.37M $4.54M
Balance Sheet
ASSETS
Cash & Equivalents $74.88M $46.34M $238.48M
Short-term Investments $96.46M $150.92M $56.62M
Accounts Receivable $38.37M $11.80M $14.90M
Inventory $35.31M $27.89M $28.55M
Other Current Assets $46.55M $31.36M $34.85M
Current Assets $291.58M $268.31M $373.39M
PP&E (Net) $82.42M $85.37M $84.22M
Goodwill $67.60M $1.93M $1.93M
Intangible Assets $5.07M $5.27M $1.07M
Other Noncurrent Assets $20.13M $26.76M $7.43M
Noncurrent Assets $500.60M $125.54M $101.81M
Total Assets $792.18M $393.84M $475.20M
LIABILITIES
Accounts Payable $9.03M $6.79M $9.58M
Other Current Liabilities $5.53M $4.36M $5.52M
Current Liabilities $171.03M $81.84M $104.13M
Long-term Debt $354.64M $36.05M $268.70M
Other Noncurrent Liabilities (derived) $317.53M $354.77M $348.54M
Noncurrent Liabilities $672.17M $390.82M $617.24M
Total Liabilities $843.20M $472.66M $721.37M
EQUITY
Common Stock $3.08M $3.03M $2.70M
Additional Paid-in Capital $3.14B $3.12B $2.98B
Retained Earnings $-3.20B $-3.20B $-3.23B
Accumulated OCI $115.00K $1.11M -
Total Equity $-51.02M $-78.82M $-246.17M
Total Liabilities & Equity $792.18M $393.84M $475.20M
SUPPLEMENTAL
Shares Outstanding 307.83M 302.96M 270.03M
Check: A − (L + E + NCI) - - -
Cash Flow Statement
Cash from Operations $18.26M $42.51M $34.09M
Capital Expenditures $4.57M $9.69M $42.44M
Cash from Investing $-304.80M $-96.65M $-1.99M
Cash from Financing $315.10M $-137.27M $136.61M
Free Cash Flow $13.69M $32.82M $-8.35M
Beginning Cash (CFS) $47.08M $238.48M -
Net Change in Cash $28.55M $-191.40M -
Effect of FX on Cash - - -
Calculated Ending Cash $75.63M $47.08M -
Cash per BS $74.88M $46.34M $238.48M
Cash scope difference (CFS − BS) $745.00K $737.00K -
Cash per CFS $75.63M $47.08M $238.48M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is MANNKIND CORP's annual revenue?

MANNKIND CORP reported $393.63M in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is MANNKIND CORP profitable?

No. MANNKIND CORP reported $-43.61M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

Does MANNKIND CORP generate free cash flow?

No. Free cash flow was $-18.14M for trailing twelve months. Operating cash flow was $-8.05M.